BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Biotech Bay

  Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference

  Jasper Therapeutics, Inc. today announced that management will present at the Oppenheimer 34th Annual Healthcare Conference at 4:40pm EST on February 13, 2024. The conference is being held in a virtual format.

  February 7, 2024

   · 

  4 min read
• Business

  Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive OfficerProven Industry Executive Brings More Than 25 Years of Leadership Experience

  Terns Pharmaceuticals, Inc. today announced the appointment of Amy Burroughs as chief executive officer (CEO), effective immediately.

  February 7, 2024

   · 

  5 min read
• Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method

  Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the U.S. Patent and Trademark Office issued a new patent, number US 11,883,429, covering AllocetraTM, the Company’s immunotherapy product candidate.

  February 7, 2024

   · 

  3 min read
• Genetown

  CereVasc’s eShunt™ System to be Presented at the International Stroke Conference by Dr. Pedro Lylyk

  CereVasc, Inc. announced that Dr. Pedro Lylyk, Director General of ENERI, will deliver a symposium presentation entitled, “Endovascular Shunting for Hydrocephalus After Subarachnoid Hemorrhage and Other Applications,” at the International Stroke Conference in Phoenix, Arizona on Wednesday, February 7th.

  February 7, 2024

   · 

  2 min read
• Genetown

  Remix Therapeutics to Participate in Upcoming Investor Conferences

  Remix Therapeutics today announced that management will participate in several upcoming investor conferences.

  February 7, 2024

   · 

  1 min read
• Drug Development

  Prokarium Achieves Milestone with First Patient Dosing in PARADIGM-1 Non-Muscle Invasive Bladder Cancer Clinical Trial

  Prokarium today announces the dosing of the first patient in their PARADIGM-1 Phase I/Ib clinical trial in non-muscle invasive bladder cancer (NMIBC) patients (NCT06181266).

  February 7, 2024

   · 

  2 min read
• Business

  Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024

  Castle Biosciences, Inc. today announced that it will release its financial results for the fourth quarter and year ended Dec. 31, 2023, after the close of market on Wednesday, Feb. 28, 2024.

  February 7, 2024

   · 

  2 min read
• Business

  BridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in Japan

  - BridgeBio grants Kyowa Kirin exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan.

  February 7, 2024

   · 

  9 min read
• Business

  Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry

  Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry.

  February 7, 2024

   · 

  4 min read
• Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program

  Cybin Inc. today announced that the Japan Patent (“JP”) Office has granted JP patents 2023-500532 and 2023-533436.

  February 7, 2024

   · 

  7 min read